Compare SON & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SON | STVN |
|---|---|---|
| Founded | 1899 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | 2014 | 2021 |
| Metric | SON | STVN |
|---|---|---|
| Price | $50.71 | $21.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $60.13 | $25.67 |
| AVG Volume (30 Days) | ★ 1.1M | 351.4K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.39% | 0.39% |
| EPS Growth | ★ 510.30 | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $7,518,753,000.00 | N/A |
| Revenue This Year | $0.10 | $9.67 |
| Revenue Next Year | $1.82 | $9.99 |
| P/E Ratio | $72.43 | ★ $27.15 |
| Revenue Growth | ★ 41.72 | N/A |
| 52 Week Low | $38.65 | $12.89 |
| 52 Week High | $60.67 | $28.00 |
| Indicator | SON | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 52.47 |
| Support Level | $46.74 | $20.03 |
| Resistance Level | $52.71 | $22.00 |
| Average True Range (ATR) | 1.41 | 0.85 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 33.38 | 49.94 |
Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.